Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

Background Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) experience a durable clinical benefit (DCB). According to NCCN guidelines, Programmed death-ligand 1 (PD-L1) expression status determined by immunohistochemistry...

Full description

Bibliographic Details
Main Authors: Lei Jiang, Jie Tian, Wei Mu, Evangelia Katsoulakis, Ilke Tunali, Jhanelle E Gray, Robert J Gillies
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/6/e002118.full

Internet

https://jitc.bmj.com/content/9/6/e002118.full

Similar Items